Abstract:Osteocytes remodel the perilacunar matrix and canaliculi. X-linked hypophosphatemia (XLH) is characterized by elevated serum levels of fibroblast growth factor 23 (FGF23), leading to decreased 1,25 dihydroxyvitamin D 3 (1,25D) production and hypophosphatemia. Bones from mice with XLH (Hyp) have enlarged osteocyte lacunae, enhanced osteocyte expression of genes of bone remodeling, and impaired canalicular structure. The altered lacuno-canalicular (LCN) phenotype is improved with 1,25D or anti-FGF23 antibody treatment, pointing to roles for 1,25D and/or phosphate in regulating this process. To address whether impaired 1,25D action results in LCN alterations, the LCN phenotype was characterized in mice lacking the vitamin D receptor (VDR) in osteocytes (VDR f/f;DMP1Cre+ ). Mice lacking the sodium phosphate transporter NPT2a (NPT2aKO) have hypophosphatemia and high serum 1,25D levels, therefore the LCN phenotype was characterized in these mice to determine if increased 1,25D compensates for hypophosphatemia in regulating LCN remodeling. Unlike Hyp mice, neither VDR f/f;DMP1Cre+ nor NPT2aKO mice have dramatic alterations in cortical microarchitecture, allowing for dissecting 1,25D and phosphate specific effects on LCN remodeling in tibial cortices. Histomorphometric analyses demonstrate that, like Hyp mice, tibiae and calvariae in VDR f/f;DMP1Cre+ and NPT2aKO mice have enlarged osteocyte lacunae (tibiae: 0.15±0.02μm 2 (VDR f/f;DMP1Cre- ) vs 0.19±0.02μm 2 (VDR f/f;DMP1Cre+ ), 0.12±0.02μm 2 (WT) vs 0.18±0.0μm 2 (NPT2aKO), calvariae: 0.09±0.02μm 2 (VDR f/f;DMP1Cre- ) vs 0.11±0.02μm 2 (VDR f/f;DMP1Cre+ ), 0.08±0.02μm 2 (WT) vs 0.13±0.02μm 2 (NPT2aKO), p<0.05 all comparisons) and increased immunoreactivity of bone resorption marker Cathepsin K (Ctsk). The osteocyte enriched RNA isolated from tibiae in VDR f/f;DMP1Cre+ and NPT2aKO mice have enhanced expression of matrix resorption genes that are classically expressed by osteoclasts ( Ctsk , Acp5 , Atp6v0d2 , Nhedc2 ). Treatment of Ocy454 osteocytes with 1,25D or phosphate inhibits the expression of these genes. Like Hyp mice, VDR f/f;DMP1Cre+ and NPT2aKO mice have impaired canalicular organization in tibia and calvaria. These studies demonstrate that hypophosphatemia and osteocyte-specific 1,25D actions regulate LCN remodeling. Impaired 1,25D action and low phosphate levels contribute to the abnormal LCN phenotype observed in XLH.

Defects in a liver-bone axis contribute to hepatic osteodystrophy disease progression

Lecithin-Cholesterol Acyltransferase Induced By PPSacα Deficiency in Liver Regulates the Homeostasis of Liver/Bone Axis and Ameliorates Hepatic Osteodystrophy Diseas

Lecithin-Cholesterol Acyltransferase Induced By&nbsp; <i>PPSacα</i>&nbsp;Deficiency in Liver Regulates the Homeostasis of Liver/Bone Axis and Ameliorates Hepatic Osteodystrophy Diseas

FATP2 Regulates Osteoclastogenesis by Increasing Lipid Metabolism and ROS Production.

The Deubiquitinase UCHL1 Negatively Controls Osteoclastogenesis by Regulating TAZ/NFATC1 Signalling

Functional Proteomic Analysis of Nonalcoholic Fatty Liver Disease in Rat Models: Enoyl-coenzyme a Hydratase Down-Regulation Exacerbates Hepatic Steatosis

Iron accumulation induced by hepcidin1 knockout accelerates the progression of aging osteoporosis

A Murine Model of Hepatic Veno-occlusive Disease Induced by Allogeneic Hematopoietic Stem Cell Transplantation

Maintaining hypoxia environment of subchondral bone alleviates osteoarthritis progression

In vitro osteoclast differentiation enhanced by hepatocyte supernatants from high-fat diet mice

Perturbation of Specific Signaling Pathways Is Involved in Initiation of Mouse Liver Fibrosis

Impaired 1,25 dihydroxyvitamin D3 action and hypophosphatemia underlie the altered lacuno-canalicular remodeling observed in the Hyp mouse model of XLH

Quantitative proteomic analysis reveals novel insights into hepatic toxicity in mice exposed chronically to okadaic acid

Effects of mouse hepcidin 1 treatment on osteoclast differentiation and intracellular iron concentration

Dyslipidemic High-Fat Diet Affects Adversely Bone Metabolism in Mice Associated with Impaired Antioxidant Capacity.

LHPP deficiency aggravates liver fibrosis through TGF-β/Smad3 signaling

Acyloxyacyl hydrolase deficiency induces chronic inflammation and bone loss in male mice

Hedgehog signaling regulates bone homeostasis through orchestrating osteoclast differentiation and osteoclast–osteoblast coupling

Low-density lipoprotein receptor deficiency reduced bone mass in mice via the c-fos/NFATc1 pathway

Differences in bone microarchitecture between genetic and secondary iron-overload mouse models suggest a role for hepcidin deficiency in iron-related osteoporosis

Liver-bone crosstalk in non-alcoholic fatty liver disease: Clinical implications and underlying pathophysiology